SSGCID is one of two Centers funded by NIAID in response to RFP-NIAID-DMID-NIHAI2016061, RFP-NIH-NIAID-DMID-07-19, RFP-NIAID-DMID-NIHAI2011124, and RFP 75N93021R00009 and is a consortium of six institutions (Seattle Children's Research Institute, University of Washington, Hampton University, University of Kansas, Washginton University in St. Louis and Washington State University). The other funded center (CSBID) is based out of Chicago, IL. SSGCID’s primary mission is to determine the 3D atomic structures of proteins and other molecules with an important biological role in human pathogens themselves, or molecules involved in host-pathogen interactions, by applying state-of-the art high-throughput (HTP) technologies and methodologies. Pathogens include those on the NIAID Category A-C agents as well as emerging and re-emerging infectious disease organisms, each year for a period of five years. This program will also support research projects that utilize experimental approaches to better characterize the molecular mechanisms of protein targets and gain further insight into the functional roles of these targets.

SUBMIT TARGETS FOR STRUCTURE DETERMINATION

AVAILABLE MATERIAL

SSGCID clones and proteins are available to order free of charge. 

PUBLISH OUR STRUCTURES

We are looking for authors to drive publication of any of our structures.  Want to be first/last author? You can! Contact SSGCID Outreach.

Organisms Studied

Overview of results